Low number messages so far today. Whats up?

Do we have confirmation that aseptisure is being tested for the bed bug issue? I can't recall seeing this from the company. Please give link in response. Thanks.

I look foward to this. I will be there, already registered.

I am uncertain from your comments what level of presentation to expect at the Miami exposition in August. Would it be a device, although un patented. Or just a poster board picture of what to expect in the next 2 years. I was, prior to your comments, expecting to see a functioning marketable device.

This is FIME list for August. It includes registration for those who want to attend.


http://www.fimeshow.com/attend_exhibitor_list2.cfm

Been away for awhile, what journal was Shannon's article in. In advance thank you.

Confidence, only if he is dedicating ALL his time to Aseptisure. Is he still going to be preoccupied elswhere?

Any more information on peer review? This would, if published in a well respected journal add substantial crediblity to business plan as stated.

Very, very well said. Takes the credibility out of every word.

I look foward to a peer review article. But can anyone explain why it is being presented without revealing, which journal? In the event the article is not accepted there is no shame, they may ask for more substance. It seems information is presented in riddle format. Can't we get over this so late in the game?

Thanks.

BenK, I wanted to call ADR to speak to a rep. Would you happen to know how to find the phone number. In advance thank you. Exciting news.

Draw downs mean higher trading level. Benk I like that.

yes

I think after the dilution is done you will be able to again.

Tuesday , December 14, 2010 10:25ET


New York, NY, December 14, 2010-Ebitda News reports that negative EBITDA for Medizone International Inc (OTC:MZEI) for its quarter ended September 30, 2010 was $(1,672,968), a 259% deterioration over the year earlier same quarter when Medizone generated $(466,388) in negative EBITDA. Medizone has generated twenty-seven consecutive quarters of negative EBITDA. EBITDA for the most recent quarter also reached a twelve year low.

For Medizone's twelve months ended September 30, 2010 EBITDA was $(2,713,261), compared with $(1,300,996), a 109% deterioration over the comparable year earlier twelve months. EBITDA for the most recent twelve months also reached a eleven year low.

The shares of Medizone were recently trading at $0.20.

EBITDA defined by Ebitda News:

EBITDA is an acronym for (Earnings Before Interest Taxes Depreciation & Amortization) and it is calculated by taking Operating Income and adding or subtracting depreciation and/or amortization.

EBITDA is a relatively new performance metric that came into vogue during the 1980s.

The reason why is because corporations in the 1980s significantly increased the use of debt to finance their operations and acquisitions. Many investors and analysts believe that the increased interest expense as a percentage of total income due to the significant increase in debt masks the performance of an operating business and thus reduces the valuation of that business when traditional valuation metrics such as after tax income are utilized. EBITDA was created so that investors and analysts would be able to understand a company’s cash earnings power before non-cash items such as depreciation and amortization and interest and taxes were expensed. EBITDA has also become an increasingly popular performance measure for global investors and analysts because many countries have varying corporate tax rates. The simple theory behind EBITDA is that it is the actual profit that a business or corporation would generate if it were to be sold to an all cash buyer.

Ebitda News is currently the only "EBITDA" news source for over 8,000 public companies for monitoring and reporting on EBITDA. It currently publishes over 30,000 stories per year related to EBITDA and is the leading global source for EBITDA related news. Ebitda News’s company, industry, indices, sector and ETF news and archives are available at www.StockTrendNews.com.

Copyright 2010 Stock News Pro LLC



Public Companies Associated with this story:
MZEI

REGARDS.

Threw this is a record, amazing, 27 quarters.

I easily see your point. Thanks

With the recent price increase I wonder if this information was leaked and this great news is already priced into the share price.

If it was a monster it would be at least .42 as it was when it was not as much a "monster"

OMG NEWS hope we dont drop again





http://finance.yahoo.com/news/AsepticSure-Eliminates-prnews-3087426558.html?x=0&.v=1

Is trading halted? I see no trades on my browser.

Looks like a .07 base soon. Not suprising considering news keeps going in circles.
We need a company embraced timeline with a goal of now we are ready for sales. Less confusion as to goals and more purpose. Sometimes I feel like I'm watching a cheerleader convention.

You are right on. New approach,same outcome.

It is wonderful to see the repetative comments here have slowed to just a few a day. This may become a legitimate message board after all.

Is the 2 hr turnaround time a change from the previous 30 minutes? That may be a little long in a busy hospital setting. 30 minutes was testing long. Of course 2hrs would not be long if it was a daily procedure. Is the protocol available anywhere?

With all this stellar news, why wont the media report these events? This sterilization subject is extraordinarily important and we get no respect. I just dont get it.

going down


no sales.

why?

Threw what date was this written?

Continued momentum should test .30 to .35. I agree with base at.25. However a drop back below .20 sustained, would be a failure of confidence. Long and strong.

Threw, probably, however volume is too low for now(125mill shares outstanding), would need confidence in news at aroud 3 to 5 million shares to give good support at .20 So I think it will return to the 10 to 13 cents range. Better for the people to buy then. Ive been wrong before. However I like your optimism. Long and Strong